2008Evidence-Based NursingRequires access

Review: varenicline, bupropion, and nicotine replacement therapies are effective for smoking cessation at 6 or 12 monthsCommentary

Kimberley Lamarche

Open publisher page 1 citations

Abstract

M J Eisenberg Dr M J Eisenberg, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada; mark.eisenberg@mcgill.ca How do various pharmacotherapies compare for smoking cessation? Studies selected compared any pharmacotherapy with placebo and reported biochemically validated measures of smoking abstinence. Trials that were unblinded or that evaluated reduced cigarette use, spontaneous cessation among smokers unwilling to quit, or smokers with chronic disease were excluded. Outcome was smoking cessation. Medline, EMBASE/Excerpta Medica, Cochrane Library , and US Centers for Disease Control and Prevention’s Tobacco Information and Prevention database were searched for randomised controlled trials (RCTs). 69 RCTs (n = 32 908) …

About this research paper

What this paper is about

M J Eisenberg Dr M J Eisenberg, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada; mark.eisenberg@mcgill.ca How do various pharmacotherapies compare for smoking cessation? Studies selected compared any pharmacotherapy with placebo and reported biochemically validated measures of smoking abstinence. Trials that were unblinded or that evaluated reduced cigarette use, spontaneous cessation among smokers unwilling to quit, or smokers with chronic disease were excluded. Outcome was smoking cessation. Medline, EMBASE/Excerpta Medica, Cochrane Library , and US Centers for Disease Control and Prevention’s Tobacco Information and Prevention database were searched for randomised controlled trials (RCTs). 69 RCTs (n = 32 908) …

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

M J Eisenberg Dr M J Eisenberg, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada; mark.eisenberg@mcgill.ca How do various pharmacotherapies compare for smoking cessation? Studies selected compared any pharmacotherapy with placebo and reported biochemically validated measures of smoking abstinence. Trials that were unblinded or that evaluated reduced cigarette use, spontaneous cessation among smokers unwilling to quit, or smokers with chronic disease were excluded. Outcome was smoking cessation. Medline, EMBASE/Excerpta Medica, Cochrane Library , and US Centers for Disease Control and Prevention’s Tobacco Information and Prevention database were searched for randomised controlled trials (RCTs). 69 RCTs (n = 32 908) …

Key concepts: Varenicline, Bupropion, Smoking cessation, Medicine, Nicotine replacement therapy, Nicotine, Pharmacology, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Review: varenicline, bupropion, and nicotine replacement therapies are effective for smoking cessation at 6 or 12 monthsCommentary — Research Paper | ScholarLens